Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden Anstalt des öffentlichen Rechts des Freistaates Sachsen
ZKN Logo
  • The Center
    • Multiple Sclerosis Center Dresden
      • Patient Information
      • Contact MSC
      • Physicians & Nurses
      • Study Team
      • Neuropsychology
    • Mobility Center
      • The Mobility Center
      • Walking Assessment
      • Jump Assessment
      • DIERS
      • EMIQ
      • Projects
    • Neuroimmunological Laboratory
      • The NIL
      • Neurofilament light chain
    • Autonomic & Neuroendocrinological Functional Laboratory
      • The ANF
      • ANF Assessment
    • MS Living Lab
    • Management & Science
      • Team Management & Science
      • Projects
      • eHealth & Analytics
        • MSDS 3D
        • MSDS Clinic & Practice
        • MS-HRS
        • MTRS
      • Multiple Sclerosis Management
  • Aktuelles
    • Neuigkeiten
    • Publikationen
    • Veranstaltungen
      • Adventssymposium
      • Multiple Sklerose 360°
      • Welt-MS-Tag 2021
    • Doktorarbeiten
    • Jobs
    • Kontakt
  • Podcasts & Newsletter
    • Newsletter
    • Patienten-Podcast
    • Ärzte-Podcast
    • Neurovision
    • Immune cell calender 25
    • Sherlock-MS-Blog
  • Studien
    • Interventionelle Studien
    • B-SHUTTLE
    • Nicht-interventionelle Studien
    • MS PATHS
    • Konectom
    • Sprachanalyse
English (UK)
Deutsch
English (UK)

Rule-Based DSL for Continuous Features and ML Models Selection in Multiple Sclerosis Research

MASC

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Zhao W, Wendt K, Ziemssen T, Aßmann U.

Verlag

Publisher-Information
Applied Sciences. 2024; 14(14):6193.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/app14146193

Tags

Forschungsthemen
Multiple SkleroseManagement & ScienceeHealth
MSZMASCeHealth2024

  • A plain language summary of a study exploring the experiences of people with relapsing–remitting multiple sclerosis: what symptoms and impacts of the disease matter most and how can they be evaluated better?

    MS Treatments
    Jahr
    2025

  • Cost–consequence analysis of early vs. delayed natalizumab use in highly active relapsing–remitting multiple sclerosis: a simulation study

    MASC
    Jahr
    2025

  • RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis

    Other
    Jahr
    2024

  • Funktionelle Elektrostimulation zur Versorgung bei paretischen Gangstörungen: Fokus auf Fußheberschwäche bei Multipler Sklerose

    Mobility
    Jahr
    2024

  • Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease

    Multiple Sclerosis
    Jahr
    2024
  • Start
  • Aktuelles
  • Publikationen
  • MASC
  • Rule-Based DSL for Continuous Features and ML Models Selection in Multiple Sclerosis Research
Impressum & Datenschutz

© 2024
Universitätsklinikum C.G. Carus Dresden an der Technischen Universität Dresden